Publicité R▼
4-Aminopyridine (n.)
1.(MeSH)One of the POTASSIUM CHANNEL BLOCKERS, with secondary effect on calcium currents, which is used mainly as a research tool and to characterize channel subtypes.
Publicité ▼
⇨ voir la définition de Wikipedia
4-Aminopyridine (n.) (MeSH)
Publicité ▼
4-Aminopyridine (n.) [MeSH]
Aminopyridines[Hyper.]
Wikipedia
4-Aminopyridine | |
---|---|
pyridin-4-amine |
|
Other names
4-pyridinamine, 4-Pyridylamine, Fampridine |
|
Identifiers | |
CAS number | 504-24-5 |
PubChem | 1727 |
ChemSpider | 1664 |
UNII | BH3B64OKL9 |
KEGG | D04127 |
MeSH | 4-Aminopyridine |
ChEBI | CHEBI:34385 |
ChEMBL | CHEMBL284348 |
IUPHAR ligand | 2416 |
ATC code | N07 |
Jmol-3D images | Image 1 |
|
|
|
|
Properties | |
Molecular formula | C5H6N2 |
Molar mass | 94.1146 |
Appearance | colourless solid |
Melting point |
155-158 °C |
Boiling point |
273 °C, 546 K, 523 °F |
Solubility in water | polar organic solvents |
Pharmacology | |
Bioavailability | 96% |
Routes of administration |
Oral |
Legal status |
|
Pregnancy category |
C(US) |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
4-Aminopyridine (INN fampridine, USAN dalfampridine) is an organic compound with the chemical formula C5H4N–NH2. The molecule is one of the three isomeric amines of pyridine. It is used primarily as a research tool, in characterizing subtypes of potassium channel, and has also been used to manage some of the symptoms of multiple sclerosis,[1][2] and is indicated for symptomatic improvement of walking in adults with several variations of the disease.[3] The drug has orphan drug status in the United States under the trade name Neurelan. It was undergoing Phase III clinical trials as of 2008[update],[4] and the U.S. Food and Drug Administration (FDA) approved the compound on January 22, 2010.[5] Fampridine is also marketed as Ampyra (pronounced "am-PEER-ah," according to the maker's website) in the United States by Acorda Therapeutics[5][6] and as Fampyra in Europe. The medication is approved for use in Canada by Health Canada on February 10, 2012. [7]
Contents |
4-Aminopyridine (4-AP) is prepared by the decarbonylation of pyridine-4-carboxamide using sodium hypochlorite via the Hofmann rearrangement. The pyridine carboxamide is generated from the corresponding nitrile, which in turn is obtained from ammoxidation of 4-methylpyridine.[8]
The largest scale industrial application of 4-aminopyridine is as a precursor to the drug pinacidil, which affects potassium ion channels.
In the laboratory, 4-AP is a useful pharmacological tool in studying various potassium conductances in physiology and biophysics. It is a relatively selective blocker of members of Kv1 (Shaker, KCNA) family of voltage-activated K+ channels. At concentration of 1 mM it selectively and reversibly inhibits Shaker channels without significant effect on other sodium, calcium, and potassium conductances.
4-Aminopyridine is also used as a bird control agent, under the trade name Avitrol; it causes convulsions and typically death, depending on dosage.[9] The use of 4-aminopyridine in bird control has been criticized by the Humane Society of the United States.[10]
Fampridine has been used clinically in Lambert-Eaton myasthenic syndrome and multiple sclerosis. It acts by blocking potassium channels, prolonging action potentials and thereby increasing neurotransmitter release at the neuromuscular junction.[11] The drug has been shown to reverse saxitoxin and tetrodotoxin toxicity in tissue and animal experiments.[12][13][14][15]
This section needs additional citations for verification. (December 2008) |
Fampridine has been shown to improve visual function and motor skills and relieve fatigue in patients with multiple sclerosis (MS). 4-AP is most effective in patients with the chronic progressive form of MS, in patients who are temperature sensitive, and in patients who have had MS for longer than three years. Common side effects include dizziness, nervousness and nausea, and the incidence of adverse effects was shown to be less than 5% in all studies.
4-AP works as a potassium channel blocker. Electrophysiologic studies of demyelinated axons show that augmented potassium currents increase extracellular potassium ion concentration which decreases action potential duration and amplitude which may cause conduction failure. Potassium channel blockade reverses this effect. A study has shown that 4-AP is a potent calcium channel activator and can improve synaptic and neuromuscular function by directly acting on the calcium channel beta subunit.[16]
MS patients treated with 4-AP exhibited a response rate of 29.5% to 80%. A long-term study (32 months) indicated that 80-90% of patients who initially responded to 4-AP exhibited long-term benefits. Although improving symptoms, 4-AP does not inhibit progression of MS.
Spinal cord injury patients have also seen improvement with 4-AP therapy. These improvements include sensory, motor and pulmonary function, with a decrease in spasticity and pain.[17]
Case reports have shown that overdoses with 4-AP can lead to paresthesias, seizures,[18] and atrial fibrillation.[19]
The drug was originally intended, by Acorda Therapeutics, to have the brand name Amaya, however the name was changed to Ampyra to avoid potential confusion with other marketed pharmaceuticals.[20]
|
Contenu de sensagent
dictionnaire et traducteur pour sites web
Alexandria
Une fenêtre (pop-into) d'information (contenu principal de Sensagent) est invoquée un double-clic sur n'importe quel mot de votre page web. LA fenêtre fournit des explications et des traductions contextuelles, c'est-à-dire sans obliger votre visiteur à quitter votre page web !
Essayer ici, télécharger le code;
SensagentBox
Avec la boîte de recherches Sensagent, les visiteurs de votre site peuvent également accéder à une information de référence pertinente parmi plus de 5 millions de pages web indexées sur Sensagent.com. Vous pouvez Choisir la taille qui convient le mieux à votre site et adapter la charte graphique.
Solution commerce électronique
Augmenter le contenu de votre site
Ajouter de nouveaux contenus Add à votre site depuis Sensagent par XML.
Parcourir les produits et les annonces
Obtenir des informations en XML pour filtrer le meilleur contenu.
Indexer des images et définir des méta-données
Fixer la signification de chaque méta-donnée (multilingue).
Renseignements suite à un email de description de votre projet.
Jeux de lettres
Les jeux de lettre français sont :
○ Anagrammes
○ jokers, mots-croisés
○ Lettris
○ Boggle.
Lettris
Lettris est un jeu de lettres gravitationnelles proche de Tetris. Chaque lettre qui apparaît descend ; il faut placer les lettres de telle manière que des mots se forment (gauche, droit, haut et bas) et que de la place soit libérée.
boggle
Il s'agit en 3 minutes de trouver le plus grand nombre de mots possibles de trois lettres et plus dans une grille de 16 lettres. Il est aussi possible de jouer avec la grille de 25 cases. Les lettres doivent être adjacentes et les mots les plus longs sont les meilleurs. Participer au concours et enregistrer votre nom dans la liste de meilleurs joueurs ! Jouer
Dictionnaire de la langue française
Principales Références
La plupart des définitions du français sont proposées par SenseGates et comportent un approfondissement avec Littré et plusieurs auteurs techniques spécialisés.
Le dictionnaire des synonymes est surtout dérivé du dictionnaire intégral (TID).
L'encyclopédie française bénéficie de la licence Wikipedia (GNU).
Copyright
Les jeux de lettres anagramme, mot-croisé, joker, Lettris et Boggle sont proposés par Memodata.
Le service web Alexandria est motorisé par Memodata pour faciliter les recherches sur Ebay.
La SensagentBox est offerte par sensAgent.
Traduction
Changer la langue cible pour obtenir des traductions.
Astuce: parcourir les champs sémantiques du dictionnaire analogique en plusieurs langues pour mieux apprendre avec sensagent.
calculé en 0,047s